Are Næss

1.3k citations
55 papers · 888 indexed · h-index 16
Topics
Bacterial Infections and Vaccines (15 papers)Pneumonia and Respiratory Infections (11 papers)Multiple Sclerosis Research Studies (9 papers)
Partner nations
NorwayQatarEthiopia

In The Last Decade

Are Næss

52 papers receiving 839 citations

Peers

Are Næss
Comparison fields: 5 of 96
  • Epidemiology 402
  • Microbiology 253
  • Immunology 233
  • Infectious Diseases 154
  • Oncology 107
Replace Marieke Emonts with:
Marieke Emonts Netherlands
Steinn Jónsson Iceland
J. H. Wandall Denmark
Irene S. Kourbeti Greece
I V Weller United Kingdom
Victoria Schauf United States
Husn H. Frayha Saudi Arabia
Laurent Bélec France
R. Jaussaud France
Nancy H. Augustine United States
Are Næss relative to Marieke Emonts Netherlands Marieke Emonts's profile →
Citations per field
00.5×1.5×2.2×
Marieke Emonts · 1×
Citations per year

Countries citing papers authored by Are Næss

Since Specialization
Citations

This map shows the geographic impact of Are Næss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Are Næss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Are Næss more than expected).

Fields of papers citing papers by Are Næss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Are Næss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Are Næss. The network helps show where Are Næss may publish in the future.

Co-authorship network of co-authors of Are Næss

This figure shows the co-authorship network connecting the top 25 collaborators of Are Næss. A scholar is included among the top collaborators of Are Næss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Are Næss. Are Næss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 1
3 27
4 6
5 0
6 14
7 67
8 2
9 40
10 16
11 91
12 27
13 38
14 27
15 22
16 3
17 14
18 1
19 2
20
The E-rosette test: variations in results using E from different sheep. Effect of FCS and of AET treatment.
1

About Are Næss

Are Næss is a scholar working on Microbiology, Virology and Immunology, having authored 55 papers that have together received 888 indexed citations. Recurring topics across this work include Bacterial Infections and Vaccines (15 papers), Pneumonia and Respiratory Infections (11 papers) and Multiple Sclerosis Research Studies (9 papers). The work is most often cited by research in Microbiology (253 citations), Epidemiology (402 citations) and Immunology (233 citations). Are Næss has collaborated with scholars based in Norway, Qatar and Ethiopia. Frequent co-authors include Haakon Sjursen, Alfred Halstensen, C. O. Solberg, Geir Egil Eide, Harald Nyland, Hilde‐Kari Guttormsen, Degu Jerene, Bernt Lindtjørn, Lee M. Wetzler and Anders Waage. Their work appears in journals such as The Journal of Infectious Diseases, Infection and Immunity and AIDS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026